Search hospitals > Iowa > Davenport
Genesis Medical Center - East Campus
Claim this profileDavenport, Iowa 52803
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Melanoma
117 reported clinical trials
2 medical researchers
Summary
Genesis Medical Center - East Campus is a medical facility located in Davenport, Iowa. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Melanoma and other specialties. Genesis Medical Center - East Campus is involved with conducting 117 clinical trials across 190 conditions. There are 2 research doctors associated with this hospital, such as David M. Spector and Nicolas Shammas.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
2Lung Cancer
Global LeaderStage II
Stage III
Stage I
Top PIs
David M. SpectorGenesis Cancer Care Institute5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
20 reported clinical trials
39 drugs studied
Nicolas ShammasMidwest Cardiovascular Research Foundation8 years of reported clinical research
Studies Peripheral Artery Disease
Studies Peripheral Arterial Disease
10 reported clinical trials
13 drugs studied
Clinical Trials running at Genesis Medical Center - East Campus
Lung Cancer
Non-Small Cell Lung Cancer
Multiple Myeloma
Cancer
ALK Gene Rearrangement
Thyroid Cancer
Leukemia
Skin Cancer
Pancreatic Cancer
Esophageal Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Data Repository
for Cancer Research
The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls. The distinct characteristic of the iCaRe2 is its geographical coverage, with a significant percentage of small and rural hospitals and cancer centers. The iCaRe2 advances comprehensive studies of risk factors of cancer development and progression and enables the design of novel strategies for prevention, screening, early detection and personalized treatment of cancer. Centers with expertise in cancer epidemiology, genetics, biology, early detection, and patient care can collaborate by using the iCaRe2 as a platform for cohort and population studies.
Recruiting1 award N/A6 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Genesis Medical Center - East Campus?
Genesis Medical Center - East Campus is a medical facility located in Davenport, Iowa. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Melanoma and other specialties. Genesis Medical Center - East Campus is involved with conducting 117 clinical trials across 190 conditions. There are 2 research doctors associated with this hospital, such as David M. Spector and Nicolas Shammas.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.